Complications and mortality in patients undergoing transcatheter aortic valve replacement with edwards SAPIEN & SAPIEN XT valves: A meta-analysis of world-wide studies and registries comparing the transapical and transfemoral accesses

Journal of Interventional Cardiology

Volumn 28, Issue 3, 2015, Pages 266-278

  Ghatak, Abhijit ^a   Bavishi, Chirag ^b   Cardoso, Rhanderson N ^a   MacOn, Conrad ^a   Singh, Vikas ^a   Badheka, Apurva O ^c   Padala, Santosh ^d   Cohen, Mauricio G ^a   Mitrani, Raul ^a   O'Neill, William ^e   De Marchena, Eduardo ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d ALBANY MEDICAL CENTER   (United States)

^e HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; AORTA STENOSIS; ARTICLE; CAUSAL ATTRIBUTION; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; HIGH RISK PATIENT; HUMAN; META ANALYSIS; PERCUTANEOUS AORTIC VALVE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RISK ASSESSMENT; SURGICAL MORTALITY; SYSTEMATIC REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; VASCULAR ACCESS; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; ARTIFICIAL HEART PACEMAKER; HEART VALVE PROSTHESIS; HEMORRHAGE; MORTALITY; PROCEDURES; RENAL REPLACEMENT THERAPY; STROKE;

ACUTE KIDNEY INJURY; HEART VALVE PROSTHESIS; HEMORRHAGE; HUMANS; PACEMAKER, ARTIFICIAL; RENAL REPLACEMENT THERAPY; STROKE; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84930867372     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/joic.12201     Document Type: Article

References (51)

1. Leon MB., Transcatheter aortic valve replacement: A breakthrough medical therapy! The 20-year odyssey, and now, a 10-year anniversary. Arch Cardiovasc Dis 2012; 105: 129-131.
2. Leon MB, Smith CR, Mack M, et al., Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607.
3. Smith CR, Leon MB, Mack MJ, et al., Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187-2198.
4. Barbash IM, Waksman R., Overview of the 2011 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting on the Edwards SAPIEN transcatheter heart valve. Circulation 2012; 125: 550-555.
5. Kappetein AP, Head SJ, Genereux P, et al., Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 2012; 60: 1438-1454.
6. Leon MB, Piazza N, Nikolsky E, et al., Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: A consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 2011; 57: 253-269.
7. DerSimonian R, Laird N., Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
8. Higgins JP, Thompson SG, Deeks JJ, et al., Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
9. Wenaweser P, Pilgrim T, Roth N, et al., Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. Am Heart J 2011; 161: 1114-1124.
10. Gurvitch R, Toggweiler S, Willson AB, et al., Outcomes and complications of transcatheter aortic valve replacement using a balloon expandable valve according to the Valve Academic Research Consortium (VARC) guidelines. EuroIntervention 2011; 7: 41-48.
11. Seiffert M, Schnabel R, Conradi L, et al., Predictors and outcomes after transcatheter aortic valve implantation using different approaches according to the valve academic research consortium definitions. Catheter Cardiovasc Interv 2013; 82: 640-652.
12. Walters DL, Sinhal A, Baron D, et al., Initial experience with the balloon expandable Edwards-SAPIEN Transcatheter Heart Valve in Australia and New Zealand: the SOURCE ANZ registry: outcomes at 30 days and one year. Int J Cardiol 2014; 170: 406-412.
13. Johansson M, Nozohoor S, Kimblad PO, et al., Transapical versus transfemoral aortic valve implantation: A comparison of survival and safety. Ann Thorac Surg 2011; 91: 57-63.
14. Rodes-Cabau J, Dumont E, De LaRochelliere R, et al., Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis. Am J Cardiol 2008; 102: 1240-1246.
15. Osten MD, Feindel C, Greutmann M, et al., Transcatheter aortic valve implantation for high risk patients with severe aortic stenosis using the Edwards Sapien balloon-expandable bioprosthesis: A single centre study with immediate and medium-term outcomes. Catheter Cardiovasc Interv 2010; 75: 475-485.
16. Zhao QM, Lognone T, Ivascau C, et al., Procedural results and 30-day clinical events analysis following Edwards transcatheter aortic valve implantation in 48 consecutive patients: Initial experience. Chin Med J (Engl) 2012; 125: 2807-2810.
17. Blackman DJ, Baxter PD, Gale CP, et al., Do outcomes from transcatheter aortic valve implantation vary according to access route and valve type? J Interv Cardiol 2014; 27: 86-95.
18. Bosmans JM, Kefer J, De Bruyne B, et al., Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: Results of the Belgian national registry. Interact Cardiovasc Thorac Surg 2011; 12: 762-767.
19. Eltchaninoff H, Prat A, Gilard M, et al., Transcatheter aortic valve implantation: Early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J 2011; 32: 191-197.
20. Ewe SH, Delgado V, Ng AC, et al., Outcomes after transcatheter aortic valve implantation: Transfemoral versus transapical approach. Ann Thorac Surg 2011; 92: 1244-1251.
21. Godino C, Maisano F, Montorfano M, et al., Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: The Milan experience. JACC Cardiovasc Interv 2010; 3: 1110-1121.
22. Lefevre T, Kappetein AP, Wolner E, et al., One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J 2011; 32: 148-157.
23. Mack MJ, Brennan JM, Brindis R, et al., Outcomes following transcatheter aortic valve replacement in the United States. JAMA 2013; 310: 2069-2077.
24. Nielsen HH, Thuesen L, Egeblad H, et al., Single center experience with transcatheter aortic valve implantation using the Edwards SAPIEN Valve. Scand Cardiovasc J 2011; 45: 261-266.
25. Rodes-Cabau J, Gutierrez M, Bagur R, et al., Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation. J Am Coll Cardiol 2011; 57: 1988-1999.
26. Svensson LG, Blackstone EH, Rajeswaran J, et al., Comprehensive analysis of mortality among patients undergoing TAVR: Results of the PARTNER trial. J Am Coll Cardiol 2014; 64: 158-168.
27. Athappan G, Gajulapalli RD, Sengodan P, et al., Influence of transcatheter aortic valve replacement strategy and valve design on stroke after transcatheter aortic valve replacement: A meta-analysis and systematic review of literature. J Am Coll Cardiol 2014; 63: 2101-2110.
28. Genereux P, Head SJ, Van Mieghem NM, et al., Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: A weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol 2012; 59: 2317-2326.
29. Rodes-Cabau J, Dumont E, Boone RH, et al., Cerebral embolism following transcatheter aortic valve implantation: Comparison of transfemoral and transapical approaches. J Am Coll Cardiol 2011; 57: 18-28.
30. Tanawuttiwat T, O'Neill BP, Cohen MG, et al., New-onset atrial fibrillation after aortic valve replacement: Comparison of transfemoral, transapical, transaortic, and surgical approaches. J Am Coll Cardiol 2014; 63: 1510-1519.
31. Erdoes G, Basciani R, Huber C, et al., Transcranial Doppler-detected cerebral embolic load during transcatheter aortic valve implantation. Eur J Cardiothorac Surg 2012; 41: 778-783.
32. Hynes BG, Rodes-Cabau J., Transcatheter aortic valve implantation and cerebrovascular events: The current state of the art. Ann N Y Acad Sci 2012; 1254: 151-163.
33. Kahlert P, Al-Rashid F, Dottger P, et al., Cerebral embolization during transcatheter aortic valve implantation: A transcranial Doppler study. Circulation 2012; 126: 1245-1255.
34. Kolh P, Lahaye L, Gerard P, Limet R., Aortic valve replacement in the octogenarians: Perioperative outcome and clinical follow-up. Eur J Cardiothorac Surg 1999; 16: 68-73.
35. Laynez A, Ben-Dor I, Barbash IM, et al., Frequency of conduction disturbances after Edwards SAPIEN percutaneous valve implantation. Am J Cardiol 2012; 110: 1164-1168.
36. Gutierrez M, Rodes-Cabau J, Bagur R, et al., Electrocardiographic changes and clinical outcomes after transapical aortic valve implantation. Am Heart J 2009; 158: 302-308.
37. Adams DH, Popma JJ, Reardon MJ, et al., Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 2014; 370: 1790-1798.
38. Ussia GP, Barbanti M, Petronio AS, et al., Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. Eur Heart J 2012; 33: 969-976.
39. Halliday BP, Dworakowski R, Brickham B, et al., Usefulness of periprocedural bleeding to predict outcome after transcatheter aortic valve implantation. Am J Cardiol 2012; 109: 724-728.
40. Borz B, Durand E, Godin M, et al., Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis. Heart 2013; 99: 860-865.
41. Barbanti M, Binder RK, Freeman M, et al., Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement. EuroIntervention 2013; 9: 929-935.
42. Toggweiler S, Gurvitch R, Leipsic J, et al., Percutaneous aortic valve replacement: Vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol 2012; 59: 113-118.
43. Hayashida K, Lefevre T, Chevalier B, et al., Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv 2011; 4: 851-858.
44. Lange R, Bleiziffer S, Piazza N, et al., Incidence and treatment of procedural cardiovascular complications associated with trans-arterial and trans-apical interventional aortic valve implantation in 412 consecutive patients. Eur J Cardiothorac Surg 2011; 40: 1105-1113.
45. Bernelli C, Chieffo A, Montorfano M, et al., Usefulness of baseline activated clotting time-guided heparin administration in reducing bleeding events during transfemoral transcatheter aortic valve implantation. JACC Cardiovasc Interv 2014; 7: 140-151.
46. Gargiulo G, Sannino A, Capodanno D, et al., Impact of postoperative acute kidney injury on clinical outcomes after TAVI: A meta-analysis of 5,971 patients. Catheter Cardiovasc Interv 2015.
47. Najjar M, Salna M, George I,. Acute kidney injury after aortic valve replacement: Incidence, risk factors, and outcomes. Expert Rev Cardiovasc Ther 2015; 13: 301-316.
48. Schnabel RB, Seiffert M, Wilde S, et al., Kidney injury and mortality after transcatheter aortic valve implantation in a routine clinical cohort. Catheter Cardiovasc Interv 2015; 85: 440-447.
49. Konigstein M, Ben-Assa E, Abramowitz Y, et al., Usefulness of updated valve academic research consortium-2 criteria for acute kidney injury following transcatheter aortic valve implantation. Am J Cardiol 2013; 112: 1807-1811.
50. Saia F, Ciuca C, Taglieri N, et al., Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors, and clinical outcome. Int J Cardiol 2013; 168: 1034-1040.
51. Aregger F, Wenaweser P, Hellige GJ, et al., Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement. Nephrol Dial Transplant 2009; 24: 2175-2179.